These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26574005)

  • 21. Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS.
    Deveson Lucas D; Crane B; Wright A; Han ML; Moffatt J; Bulach D; Gladman SL; Powell D; Aranda J; Seemann T; Machado D; Pacheco T; Marques T; Viveiros M; Nation R; Li J; Harper M; Boyce JD
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii.
    Boinett CJ; Cain AK; Hawkey J; Do Hoang NT; Khanh NNT; Thanh DP; Dordel J; Campbell JI; Lan NPH; Mayho M; Langridge GC; Hadfield J; Chau NVV; Thwaites GE; Parkhill J; Thomson NR; Holt KE; Baker S
    Microb Genom; 2019 Feb; 5(2):. PubMed ID: 30720421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired growth under iron-limiting conditions associated with the acquisition of colistin resistance in Acinetobacter baumannii.
    López-Rojas R; García-Quintanilla M; Labrador-Herrera G; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2016 Jun; 47(6):473-7. PubMed ID: 27179817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group.
    Conlon JM; Sonnevend A; Pál T; Vila-Farrés X
    Int J Antimicrob Agents; 2012 Apr; 39(4):317-20. PubMed ID: 22326566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.
    Saugar JM; Rodríguez-Hernández MJ; de la Torre BG; Pachón-Ibañez ME; Fernández-Reyes M; Andreu D; Pachón J; Rivas L
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1251-6. PubMed ID: 16569836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii.
    Martínez-Guitián M; Vázquez-Ucha JC; Odingo J; Parish T; Poza M; Waite RD; Bou G; Wareham DW; Beceiro A
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4375-9. PubMed ID: 27139471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic and phenotypic studies of bicarinalin, BP100 and colistin action on Acinetobacter baumannii.
    Eales MG; Ferrari E; Goddard AD; Lancaster L; Sanderson P; Miller C
    Res Microbiol; 2018; 169(6):296-302. PubMed ID: 29751064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of EmrAB efflux pumps to colistin resistance in Acinetobacter baumannii.
    Lin MF; Lin YY; Lan CY
    J Microbiol; 2017 Feb; 55(2):130-136. PubMed ID: 28120193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colistin Resistance in
    Hua X; Liu L; Fang Y; Shi Q; Li X; Chen Q; Shi K; Jiang Y; Zhou H; Yu Y
    Front Cell Infect Microbiol; 2017; 7():45. PubMed ID: 28275586
    [No Abstract]   [Full Text] [Related]  

  • 30. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
    Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
    J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
    Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML
    Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii.
    Durante-Mangoni E; Del Franco M; Andini R; Bernardo M; Giannouli M; Zarrilli R
    Diagn Microbiol Infect Dis; 2015 Jul; 82(3):222-6. PubMed ID: 25858028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple Genetic Mutations Associated with Polymyxin Resistance in Acinetobacter baumannii.
    Lim TP; Ong RT; Hon PY; Hawkey J; Holt KE; Koh TH; Leong ML; Teo JQ; Tan TY; Ng MM; Hsu LY
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7899-902. PubMed ID: 26438500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii.
    Chin CY; Gregg KA; Napier BA; Ernst RK; Weiss DS
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7911-4. PubMed ID: 26459891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii.
    Boll JM; Crofts AA; Peters K; Cattoir V; Vollmer W; Davies BW; Trent MS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6228-E6237. PubMed ID: 27681618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii ST2 Clinical Isolate in Algeria: First Case Report.
    Bakour S; Olaitan AO; Ammari H; Touati A; Saoudi S; Saoudi K; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):279-85. PubMed ID: 25588125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colistin Resistance in Environmental Isolates of
    Jovcic B; Novovic K; Dekic S; Hrenovic J
    Microb Drug Resist; 2021 Mar; 27(3):328-336. PubMed ID: 32762604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
    Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A
    Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.